InvestorsHub Logo
Followers 31
Posts 3757
Boards Moderated 0
Alias Born 01/29/2012

Re: chickpea598 post# 35246

Friday, 04/29/2016 10:14:36 AM

Friday, April 29, 2016 10:14:36 AM

Post# of 48316
You bet! And looks like the device is ready if you look at the words I've highlighted in extract below from REV1's website.

Established in 2011, OncoSec Medical Inc. is a San Diego-based biotechnology company pioneering new technologies to stimulate the body’s immune system to target and attack cancer. OncoSec approached REV·1 Engineering with a need for a new Electroporation & Genetic Payload Delivery device to reach internal cancerous tumors that could not be reached with their skin-based device.
REV·1 developed multiple design solutions addressing how to access the tumors, stabilize them, and deliver OncoSec's proprietary Genetic Payload, followed by electroporating the tumors.
REV·1 designed a simple hand-held unit that can be introduced in a minimally invasive out-patient setting to access tumors deep in the body. Currently in pre-clinical trials, this device, combined with OncoSec's proprietary gene therapy, will radically change the treatment of these deep-in-the-body, life-threatening tumors.


Honestly, I hope the PPS stagnates in this range for a few more months, at least till combo prelim data, as I haven't gotten to my ideal number of shares yet :)